2017-11-15T10:49:19-00:00 2016-12-31 KPMG LLP 1676 International Drive McLean VA 22102 990 2016-01-01 131623888 American Diabetes Association AMER 7035491500 2451 Crystal Drive Room 900 Arlington VA 22202 Martha P Clark Interim Chief Executive Officer 2017-11-15 true Whitney E Blair 7032868000 2017-11-15 70.168.181.226 2017-11-15 14:17:00 ES 5428392017313qt7jx75 2017-11-14 P BC1B3FDB9E699FAB45B91C0711E6813F13FD4270 BC1B3FDB9E699FAB45B91C0711E6813F13FD4270 2016 2017-02-10 21:41:12Z Martha P Clark 2451 Crystal Drive Suite 900 Arlington VA 22202 211045038 false X www.diabetes.org X 1940 OH The mission of the American Diabetes Association the Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. 18 18 1502 79627 5044118 -1667190 135304032 122553876 31874705 31123787 1660685 1689268 11963581 11967983 180803003 167334914 35992416 34536365 0 66041729 69064865 1794074 1439767 40894704 82289021 85416898 186117240 190457895 -5314237 -23122981 155505610 153302044 73633332 94350810 81872278 58951234 X The mission of the American Diabetes Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. false false 46813413 34294418 15808644 Research - See Schedule O 50216763 177299 18220418 Information - See Schedule O 40826224 64648 Advocacy and Public Awareness - See Schedule O 1675645 137856400 true true false true true false false false true true true false true true true false true false false true true false true true true false true true true false false false false false false false false true false false false false true true true false false true 1208 1 true 1502 true true true false false false false true true false false false false true false false false false X 18 18 false false false false true true false true true false true true true true true true true true true true false AK AL AR AZ CA CO CT DC FL GA HI IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NH NJ NY OH OK OR PA RI SC TN UT VA WA WI WV X X Charlotte M Carter CFO 7035491500 2451 Crystal Drive Suite 900 Arlington VA 22202 X Robin J Richardson Chair of the Board 006.00 X X 0 0 0 Desmond Schatz MD President, Medicine Science 006.00 X X 0 0 0 Margaret A Powers PhD RD CDE President, Health Care Education 006.00 X X 0 0 0 Lorrie Welker Liang Secretary-Treasurer 006.00 X X 0 0 0 David A DeMarco PhD Chair of the Board-Elect 002.00 X X 0 0 0 Alvin Powers MD President-Elect, Medicine Science 002.00 X X 0 0 0 Brenda Montgomery RN MSHS CDE President-Elect, Health Care Education 002.00 X X 0 0 0 Umesh Verma Secretary/Treasurer-Elect 002.00 X X X 0 0 0 Jackie Boucher MS RD LD CDE Board of Directors 001.00 X 0 0 0 Martha Clark MBA Board of Directors 001.00 X 0 0 0 Robert Eckel MD Board of Directors 001.00 X 0 0 0 David Herrick MBA Board of Directors 001.00 X 0 0 0 Felicia Hill-Briggs PhD ABPP Board of Directors 001.00 X 0 0 0 Jeffrey Himmel MS Board of Directors 001.00 X 0 0 0 Jane Reusch MD Board of Directors 001.00 X 0 0 0 Calvin Schmidt MBA Board of Directors 001.00 X 0 0 0 Catherine Squires CFRE Board of Directors 001.00 X 0 0 0 Alan Yatvin JD Board of Directors 001.00 X 0 0 0 Kevin L Hagan Chief Executive Officer 036.90 000.60 X X 474856 0 49241 Charlotte M Carter Chief Financial Officer 037.00 000.50 X 278806 0 23372 Cynthia J Hallberlin Chief Operating Officer 037.50 X 355933 0 30514 Robert Ratner Departure date 121916 Chief Scientific and Medical Officer 037.50 X 449519 0 21403 Corey Gordon Chief Development and Stewardship Officer 037.50 X 296023 0 27698 Jeanette Flom Departure date 91616 VP Eastern Division 037.50 X 142350 0 13485 Rodney Sampson Departure date 72216 SVP ITS and Chief Technical Officer 037.50 X 119768 0 7330 Christa Wilson Interim SVP ITS and Chief Technical Officer 037.50 X 146413 0 18813 Kimberly Baich Chief Marketing and Communications Officer 037.50 X 245128 0 23886 Suehila Glass SVP Field Development Operations 037.50 X 187883 0 28618 Tamara Darsow PhD VP Research Programs 037.50 X 196962 0 34302 Shereen Arent Chief Advocacy Officer 037.50 X 238385 0 21152 Linda Cann VP Professional Education 037.50 X 182330 0 29497 Jonathan Webb VP Corporate Alliance 037.50 X 155380 0 23653 Michael Eisenstein SVP Products and Publications 037.50 X 177916 0 16678 Peter Banfield Departure date 12516 SVP Operations Integration 037.50 X 252290 0 25519 Jane Chiang Departure date 112516 SVP Medical Community Affairs 037.50 X 272992 0 11073 Michael Chae Regional Director 037.50 X 163210 0 30209 Christopher Boynton Vice President, East Territory 037.50 X 177151 0 32271 Suzanne Werdann Vice President, Sports Entertainment 037.50 X 175630 0 9925 Deborah L Johnson Departure date 10 Chief Financial Officer X 196132 0 0 Greg Elfers Departure date 8715 Chief Field Development Officer X 205069 0 0 Andrea Maddox Departure date 11615 SVP Eastern Key Mkts Program Implementation X 110434 0 0 Geraldine W Brown Departure date 10 Director of Corporate Development X 200000 0 0 5400560 478639 90 true true false Infocision Management Corporation 325 Springside Drive Akron OH 44333 Professional Fundraising 1587480 NNE Marketing LLC 1666 Massachusetts Avenue Ste 14 Lexington MA 02420 Professional Fundraising Consulting 672000 Blackbaud Inc 11501 Domain Drive Ste 200 Austin TX 78758 Constituent Records Application Technical Services 1301255 Proskauer Rose LLP Eleven Times Square New York NY 10036 Legal Consulting 544666 Broadaxis Inc 2591 Dallas Pkwy Ste 300 Frisco TX 75034 Information Systems 489810 34 5135359 40679262 639511 76099744 2511915 122553876 Subscriptions 511120 10704765 10704765 Registration 611710 10841535 10841535 Sales of Material 511130 3703144 3703144 Booth Rental 611710 4971892 4971892 Other Program Service Revenue 900099 902451 902451 31123787 1608097 1608097 2729211 2729211 35503153 35340965 81017 162188 -81017 81171 81171 8272339 40679262 8272339 34645 15803 18842 18842 Advertising Income 541800 4639012 4639012 Catalog Sales Income - Gift of Hope 454110 405106 405106 Abstract Fees Permissions Income 900099 846760 846760 3329052 3329052 9219930 167334914 30327707 5044118 9409213 34474632 34474632 48242 48242 13491 13491 0 4296233 2834921 304263 1157049 0 50581779 33733412 3815900 13032467 1393682 933662 96894 363126 8405349 5395416 1005004 2004929 4387822 2893512 375384 1118926 0 1058429 559904 481072 17453 308376 18789 285004 4583 201359 201359 1439767 1439767 235847 235847 9016864 6858326 704069 1454469 5380249 3157991 60013 2162245 4531299 2853124 589752 1088423 6394737 4477887 277298 1639552 170332 170332 12660960 9328297 706647 2626016 4465277 3245134 192176 1027967 0 5722193 5572248 8303 141642 267 116 8 143 0 3002851 1397334 1046706 558811 621196 440711 39207 141278 Supplies 3480146 3130031 15494 334621 Postage and Shipping 9248550 4559767 150742 4538041 Printing and Publications 13336032 8278339 367525 4690168 Data Processing 1935840 1209593 16594 709653 3646094 2069830 932889 643375 190457895 137856400 11706791 40894704 X 25378224 8543258 826919 16008047 23931810 18372384 762084 249609 43711864 38184108 3934842 3649032 2076487 2254270 4404833 4979561 45303879 26519639 10173193 18784240 38440477 38357354 9627232 9724068 18442788 18747418 155505610 153302044 14607418 29072138 13576452 10287114 45449462 54991558 73633332 94350810 X 21170430 1085365 46715669 43786500 13986179 14079369 81872278 58951234 155505610 153302044 -23122981 201937 X false true X true false X 152820180 165940291 146055657 135304032 122553876 722674036 152820180 165940291 146055657 135304032 122553876 722674036 722674036 3097640 3544529 4009899 4560225 4337308 19549601 78260 69992 47055 33439 34645 263391 742487028 231453847 0.97330 0.97750 X 0.00000 0.00000 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true true 20000 true 45114 false false true 684591 true 15998 false 765703 false II-B The American Diabetes Associations advocacy efforts and achievements are at the core of creating effective and lasting change for people living with, and at risk for, diabetes. The Association gives people with diabetes, their families, and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state, and national levels. From Capitol Hill to state houses to court houses across the country, the Associations Diabetes Advocates continue to drive momentum in our ongoing fight to Stop Diabetes. The primary goals of the American Diabetes Associations Advocacy efforts are Increase federal and state funding for diabetes prevention, treatment and research Prevent diabetes Protect and improve the availability of accessible, adequate, and affordable health care including making insulin affordable End the discrimination people with diabetes face at school, work, and elsewhere in their lives End health disparities Advance medications and devices used to treat and monitor diabetes and prediabetes Improve federal coordination on diabetes care and management II-B While the Association succeeded in its efforts to gain congressional support for increased federal funding for diabetes research and programs, ultimately Congress did not pass a final FY2017 budget in 2016. A continuing resolution CR funded the government until April 28, 2017, with an across the board cut of 0.19 for all programs. A final FY2017 budget was agreed to in May, with the following funding levels for diabetes programs National Institute of Diabetes and Digestive and Kidney Diseases NIDDK 1.871 billion increase of 52 million over FY 2016, Division of Diabetes Translation DDT at the Centers for Disease Control and Prevention CDC 140.129 million decrease of 30 million from FY 2016, and the National Diabetes Prevention Program National DPP 22.5 million increase of 2.5 million over FY 2016. While the DDT number did decrease, it was due to the termination of a one time boost of 30 million that was received in FY 2016 to aid in the phasing out of a particular program. The Association garnered significant bipartisan support for the Special Diabetes Programs SDP 356 House members and 75 Senators signed a letter to extend the program when it comes up for reauthorization. The programs funding runs out on September 30, 2017. The Association had twelve state victories around prevention four local measures taxing sugar sweetened beverages and legislation maintaining standards for school physical education. The Food and Drug Administration FDA released an updated nutrition facts label, but its implementation has been delayed until at least 2018. II-B Progress spread across the country with 60 legislative and regulatory victories in the areas of health insurance, fighting discrimination, primary prevention, diabetes programs and surveillance, and state coordination of diabetes. Our Safe at School campaign added Idaho, Maryland, and Pennsylvania to the list of states with laws or policies meeting all of the main tenets of the campaign. By the end of the year, 32 states met these tenets, providing access to diabetes care and allowing for appropriate self-management. In all 50 states and the District of Columbia, the Association continued its efforts to fight for fairness for people with diabetes at school, on the job, in places of public accommodation, and in government programs and services. The Association continued efforts to monitor and shape implementation of the Affordable Care Act, Medicaid, and Medicare through numerous official comments, letters, friend of the court briefs, and meetings with Administration officials. Significantly, we helped secure Medicare coverage of the National Diabetes Prevention Program for seniors at-risk for diabetes. This benefit is scheduled to take effect in January 2018. II-B The Association continued its focus on underserved and disproportionately affected communities, achieving 10 victories by increasing access to fresh and healthy foods in underserved communities, securing funding for programs to reduce health disparities, and supporting the Screen at 23 campaign to promote screening for diabetes in the Asian community. Working with the Diabetes Disparities Action Council, we continued to promote public policies to reduce health disparities in the African American, American Indian/Alaska Native, Asian and Pacific Islander, and Latino communities. As part of this work, the Association builds outside support for our advocacy efforts, such as building relationships with strategic partners, including professional football players through our Team tackle initiative, the National Bar Association, National Indian Health Board, Mexican Embassy, and Telemundo and key collaborations with federal agencies, including the National Institute for Diabetes and Digestive and Kidney Diseases, Office of Minority Health, Centers for Medicare and Medicaid Services, and Health Resources and Services Administration. 1 53964 460046 true true 22460102 -3646 1972812 1895048 22534220 22540712 -2371 1593023 1671262 22460102 22695748 16761 2132726 2304523 22540712 22599517 2508624 2412393 22695748 21974370 -5113 2474180 1843920 22599517 0.19000 0.81000 true true true 67092 67092 6282897 481533 5801364 13956793 9765711 4191082 24997097 16272395 8724702 18784240 9724068 F Financial derivatives and other financial products 9724068 F Closely-held equity interests 9724068 Due From Property Title Holding Corporation 5929543 Investment in Net Assets of American Diabetes Association Property Title Holding Corporation 12817875 18747418 Federal income taxes Due to American Diabetes Association Research Foundation 54991558 54991558 X 171062420 201937 1727640 3416545 5346122 165716298 235847 1382769 1618616 167334914 190651146 1727635 244452 32684956 34657043 155994103 235847 34227945 34463792 190457895 V 4 The following was disclosed in the consolidated financial statements related to the intended use of the Association endowment funds The Association has adopted an investment policy for endowment assets that provides continued financial stability for the Association and a revenue stream for spending on the Association mission. V 4 To fulfill this mission, the American Diabetes Association funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals, and the public. X 2 The following was disclosed related to uncertain tax positions in the audited financial statements The American Diabetes Association and the American Diabetes Association Research Foundation, Inc. are exempt from income taxes under Section 501c3 of the Internal Revenue Code the Code and charitable contributions to these organizations qualify for tax deductions as described in the Code. The American Diabetes Association Property Title Holding Corporation is exempt from income taxes under Section 501c2 of the Code. These entities have been classified as organizations that are not private foundations under Section 509a of the Code. The Association recognizes the effects of the income tax positions only if those positions more likely than not would not be sustained upon examination by the Internal Revenue Service. The Association has analyzed the tax positions taken and has concluded that as of December 31, 2016, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability or asset or disclosure in the consolidated financial statements. XI 2d Donations reported by the American Diabetes Association Research Foundations audited financial statement EIN 54-1734511 2,666,455. Contributed services reported by the American Diabetes Association Research Foundation, Inc. EIN 54-1734511 750,090. XI 4b Management fee earned from the American Diabetes Association Research Foundation, Inc. EIN 54-1734511 1,382,769. XII 2d American Diabetes Association Research Foundation, Inc. EIN 54-1734511 Expenses 32,684,956. XII 4b Grant to the American Diabetes Association Research Foundation, Inc. EIN 54-1734511 34,227,945. true Europe Including Iceland and Greenland Program Services Grantmaking 13491 13491 13491 Europe Including Iceland and Greenland See Part V 13491 Check 1 false false false false false false Part I Line 3 The Association awarded a grant to the International Diabetes Federation IDF as part of the Associations donor advised fund program. The grantees use of the fund is monitored through the Associations membership in the IDF. Part II Line 1 The primary purpose of the grant is for the annual contribution from the Wendell Mayes donor advised fund to the International Diabetes Federation to support the Mary Jane Mayes scholar program. X X X X X X X true Infocision Management Corporation Telemarketing false 2206529 1349570 856959 NNE Marketing LLC See Part IV false 18766423 672000 18094423 Automotive Recovery Services Inc See Part IV true 436120 169356 266764 21409072 2190926 19218146 AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY Step Out Walk to Stop Diabetes 12719313 11239564 1479749 311465 648844 56497 61924 401019 Tour de Cure 25544115 21519065 4025050 924503 1328002 603258 161158 1008129 10688174 7920634 2767540 103602 513041 1305130 174656 671111 48951602 40679263 8272339 1339570 2489887 1964885 397738 2080259 8272339 34645 10320 5178 305 true 0.80000 34645 10320 5178 305 15803 18842 AK NJ TX true false false false 1.00000 See Part IV Supplemental Info 2451 Crystal Drive Suite 900 Arlington VA 22202 false See Part IV Supplemental Info X true 18842 Part I Line 2 The amount reported in column v represent fees paid to registered professional fundraisers. Additional payments to these vendors include the following consulting fee related to programmatic content 1,350,000, printing 210,000, postage and shipping cost 85,000, marketing expense of 39,000 and total data processing 4,000. The amount paid for these expenses were determined by review of the detailed invoices supplied by the service provider. Part I Line 2ii NNM Marketing, LLC activities are strategic services including account and project management, data processing analysis reporting, meeting, and/or project services requested by ADA. Part I Line 3ii Automotive Recovery Services, Inc. activities are advertising, acquisition and disposal of donated vehicles solicited by American Diabetes Association. Part III Line 14 The Associations records are centralized at the home office at 2451 Crystal Drive, Suite 900, Arlington, VA 22202 based on the information submitted by each Executive Director located in field offices. Part III Line 16 The management and administration of the Association gaming/special events are the responsibility of the local Executive Director of each office. Compensation of the Associations local executive directors is based on size of the market, and is not specific to the results of an individual gaming activity. true American Diabetes Association Research Foundation Inc 2451 Crystal Drive Suite 900 Arlington VA 22202 541734511 501 c3 34227945 Research Lions Camp Merrick 11855 Holly Lane Suite 104 Waldorf MD 20601 521289731 501 c3 30000 Camperships Florida Department of Health 5150 NW Milner Dr Port St Lucie FL 34983 593502843 170 c1 29500 Education and Development Lakeland Regional Health Systems Inc 1324 Lakeland Hills Blvd Lakeland FL 33805 592650464 501 c3 6000 Education and Development The SKY Family YMCA Inc 701 Center Road Venice FL 34285 591629660 501 c3 10000 Education and Development T1D First Inc 11 Ave De Lafayette 5th Floor Boston MA 02111 451623549 501 c3 100000 Education and Development The YMCA of Florida's First Coast Inc 12735 Gran Bay Pkwy West Suite 250 Jacksonville FL 32258 590638514 501 c3 6000 Education and Development Community Service Fund Raising Alliance CSFRA PO Box 230122 Anchorage AK 99523 920152006 501 c3 10000 Education and Development Tampa Metropolitan Area YMCA Inc 110 E Oak Ave Tampa FL 32162 591742909 501 c3 6000 Education and Development YMCA of The Suncoast Inc 2469 Enterprise Rd Clearwater FL 33763 590810731 501 c3 9000 Education and Development 10 Lecture Honoraria 7 47000 Travel Scientific Conferences 2 1242 Part I Line 2 The American Diabetes Association provides grant funding for research grants to the American Diabetes Association Research Foundation. The American Diabetes Association closely monitors the use of all grant funds. Each grantee is required to submit an annual progress report, which includes a scientific and a financial portion, 30 days after the end of each previously committed funding year. Each year of funding after the first is contingent upon approval of the annual progress report and the availability of funds. If the complete report is not received within 90 days after the due date, the award will be terminated. Part I Line 2 After the completion of the final year of the grant, a cumulative final report, which includes a scientific and financial portion, is due within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible to apply for any future American Diabetes Association Research Foundation awards until the obligations for the award are complete. This process is monitored and reviewed by the American Diabetes Association scientific/medical management staff for award status and compliance. Part I Line 2 The American Diabetes Association continues to be the worlds largest provider of camps for children with diabetes to help ensure the wellbeing of families affected by diabetes. The Association provides grants, scholarships and targeted youth programs for persons with diabetes. Each summer, thousands of children have the opportunity to spend time at Diabetes Camp, meeting other children with diabetes and sharing their experiences, challenges, hopes, and dreams. In 2016, the American Diabetes Association hosted 59 camp sessions in 25 states serving nearly 6,000 campers with Type I Type 2 diabetes. In addition, more than 2,000 volunteers made camp possible by donating their time and expertise. Camp provides an outdoor recreational experience in which the child for children with diabetes ages 8-18 can develop as a person while including informal education about the management of diabetes. Children are carefully supervised by a staff of doctors, nurses, dietitians, and other volunteers and staff. Program Evaluation and outcome measurement provide valuable data to the Association regarding camp programs and how to improve them. An assessment/planning meeting including camp volunteers and staff leadership is held within two months of the conclusion of the camp session. At this time, camp results are evaluated and compared to goals. The strengths and weaknesses of the camp program, opportunities for growth and improvement, emerging issues and needs and the viability of continuation/initiation of new programs are evaluated. The American Diabetes Association also provides grants to support Advocacy program. The Association monitors the use of the funds by maintaining an on-going communication and periodic financial reports. Part II Line 2 The American Diabetes Association is committed to preventing diabetes. The Diabetes Prevention Program DPP was a major multicenter clinical research study, funded in part by the American Diabetes Association, aimed at discovering whether modest weight loss through dietary changes and increased physical activity or treatment with the oral diabetes drug metformin Glucophage could prevent or delay the onset of type 2 diabetes in study participants. The DPP found that participants who lost a modest amount of weight through dietary changes and increased physical activity sharply reduced their chances of developing diabetes. Taking metformin also reduced risk, although less dramatically. The DPPs results indicate that millions of people at high-risk for developing type 2 diabetes can delay or avoid developing type 2 diabetes by losing weight through regular physical activity and a diet low in fat and calories. Weight loss and physical activity lower the risk of diabetes by improving the bodys ability to use insulin and process glucose. The DPP contributed to a better understanding of how diabetes develops in people at risk and how they can prevent or delay the development of diabetes by making behavioral changes leading to weight loss. These findings are reflected in recommendations from the American Diabetes Association for the prevention or delay of type 2 diabetes, which stress the importance of lifestyle changes, and weight loss. Building on the success of the DPP, the Centers for Disease Control and Prevention CDC led National Diabetes Prevention Program is an evidence-based lifestyle change program for preventing type 2 diabetes. The year-long program helps participants make real lifestyle changes such as eating healthier, incorporating physical activity into their daily lives and improving problem-solving and coping skills. The American Diabetes Association is collaborating with the Florida Department of Health to provide support, technical assistance and mini-grants to Florida-based Diabetes Prevention Lifestyle Change DPLC accredited programs, or pending accreditation, by the CDC. Funded wholly by a grant from the Florida Department of Health, the goals of this initiative are 1 to increase the number of DPLC program participants with a blood-based prediabetes diagnosis 2 to increase the number of DPLC program participants achieving 5-7 weight loss and 3 to increase the number of health care practices that have a policy to refer patients with or at risk for prediabetes to DPLC programs. Part III Line 1 and 2 Each year, the American Diabetes Association recognizes the outstanding contributions of individuals in the service of the diabetes community through its National Achievement Awards. These awards are presented to recognize and honor individuals in the diabetes scientific and medical community who have demonstrated exceptional leadership and who have made significant contributions through their outstanding career achievements. Barbara B. Kahn, MD received 20,000 for seminal contributions to understanding the molecular pathogenesis of obesity and type 2 diabetes. Tamas L. Horvath, DVM, PhD received 10,000 for an outstanding scientific achievement in diabetes research, taking into consideration independence of thought, originality, significance of discovery, and impact on his/her area of research. Gordon C. Weir, MD received 5,000 for an outstanding achievement in mentorship and/or creation of a robust environment for diabetes research. X X true true X X X X X true true false false false false false true false Kevin L Hagan Chief Executive Officer 471998 2857 27660 21581 524096 Charlotte M Carter Chief Financial Officer 234548 41542 2715 14387 8986 302178 Cynthia J Hallberlin Chief Operating Officer 355849 84 5111 25402 386446 Robert Ratner Departure date 121916 Chief Scientific and Medical Officer 428586 20934 20188 1214 470922 Corey Gordon Chief Development and Stewardship Officer 294292 1731 5703 21995 323721 Jeanette Flom Departure date 91616 VP Eastern Division 134805 7545 8184 5301 155835 Rodney Sampson Departure date 72216 SVP ITS and Chief Technical Officer 116007 3762 6980 350 127099 Christa Wilson Interim SVP ITS and Chief Technical Officer 145526 887 4440 14373 165226 Kimberly Baich Chief Marketing and Communications Officer 245128 1291 22595 269014 Peter Banfield Departure date 12516 SVP Operations Integration 226586 25704 2974 22545 277809 Suehila Glass SVP Field Development Operations 187799 84 6622 21996 216501 Tamara Darsow PhD VP Research Programs 188657 8306 11906 22395 231264 Jane Chiang Departure date 112516 SVP Medical Community Affairs 257981 15011 10328 745 284065 Shereen Arent Chief Advocacy Officer 237033 1351 11905 9248 259537 Linda Cann VP Professional Education 181204 1126 11300 18197 211827 Jonathan Webb VP Corporate Alliance 155380 1872 21780 179032 Michael Eisenstein SVP Products and Publications 177916 16678 194594 Michael Chae Regional Director 163210 8302 21907 193419 Christopher Boynton Vice President, East Territory 168817 8000 334 10365 21907 209423 Suzanne Werdann Vice President, Sports Entertainment 175630 1355 8570 185555 Deborah L Johnson Departure date 10 Chief Financial Officer 196132 196132 Greg Elfers Departure date 8715 Chief Field Development Officer 205069 205069 Andrea Maddox Departure date 11615 SVP Eastern Key Mkts Program Implementation 110434 110434 Geraldine W Brown Departure date 10 Director of Corporate Development 200000 200000 Part I Line 1a Payments related to additional pension benefits are grossed up for individual tax reporting purposes. Part I Line 1a The Chief Executive Officer provided compensation for travel companion included in other reportable compensation. Part I Line 4b The Chief Executive Officer is compensated by the American Diabetes Association and participated in its supplemental retirement plan. the reported retirement and other deferred compensation includes 2016 contributions to the Chief Executive Officers 457f plan totalling 18,000. Part I Line 7 The following non-fixed payment is reported for the Chief Executive Officer an accrued 457f deferred compensation contribution 18,000. Part II Line 4 Robert Ratner, Chief Scientific and Medical Officers employment ended December 19, 2016 with the American Diabetes Association. Part II Line 6 Jeanette Flom, VP Eastern Divisions employment ended September 16, 2016 with the American Diabetes Association. Part II Line 7 Rodney Sampson, SVP ITS and Chief Technical Officers employment ended July 22, 2016 with the American Diabetes Association. Part II Line 10 Peter Banfield, SVP Operations Integrations employment ended December 5, 2016 with the American Diabetes Association. Part II Line 13 Jane Chiang, SVP Medical Community Affairs employment ended November 25, 2016 with the American Diabetes Association. Part I Line 4a Geraldine W. Brown, Former Director of Corporate Development, received a severance payment in the amount of 200,000. The payment was included in her 2016 W-2 and is reflected on Schedule J, Part II, Column BIII as other reportable compensation. X 1235 302182 See Part II X 55 177280 Fair Market Value X 37070 2032453 Fair Market Value false true true Part I Line 6 The method of determining noncash contributions amounts is the sales of comparable property and/or opinion of expert to determine the fair market value. Part I Line 32b The American Diabetes Association contracts with Automotive Recovery Services, Inc. 13085 Hamilton Crossing, Suite 500, Carmel, IN 46032, to advertise for donation of vehicles, as well as receive and sell/dispose of the donated vehicles on behalf of the American Diabetes Association. Form 990, Part III, Line 4 76 Years of Leading the Fight Against Diabetes and All its Burdens Form 990, Part III, Line 4 More than 100 million Americans in the United States have diabetes or prediabetes an invasive, unrelenting and debilitating disease that spans all ages, geography and educational levels. This chronic disease targets children, the elderly and minority populations more than others and costs the United States 322 billion dollars each year in lost productivity. It is a global epidemic that contributes to heart disease, stroke, nerve and kidney disease and vision loss. Form 990, Part III, Line 4 The American Diabetes Association is the only organization dedicated specifically to the research, education and advocacy required to improve the lives of the 30.3 million adults and children in the U. S. with diabetes and the 84.1 million people with prediabetes. For 76 years, we have been working on the frontlines to educate at-risk populations, protect the rights of people with diabetes at work, school and other aspects of daily life, pioneer clinical and research breakthroughs and foster a pipeline of the best and brightest scientists. From research labs to the halls of the Capitol to the offices of health care practitioners to communities nationwide, we are there. We envision a life free of diabetes and all its burdens, which is fueled by our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Form 990, Part III, Line 4 Diabetes Research Form 990, Part III, Line 4 Accelerating Progress toward the Next Big Discovery Diabetes is an extremely complex disease caused by a combination of various genetic and environmental factors that progressively lead to an inability to produce or effectively utilize insulin. The complexity of causes conspiring to diminish the bodys production or response to insulin, leading to high blood glucose and eventual development of diabetes, makes finding a single cure particularly difficult. While a cure has been elusive, critical research efforts in recent decades have led to significantly improved patient care, resulting in fewer complications and better health outcomes for individuals with diabetes. Form 990, Part III, Line 4 As a leader in diabetes research, and the only organization dedicated specifically to the research, education and advocacy required to improve the lives of all people with diabetes, the American Diabetes Association funds critical, innovative diabetes research and invests in promising scientists early in their careers. Our direct involvement in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the Association with the framework and early leadership for a formalized diabetes research program. Form 990, Part III, Line 4 Since our Research Programs inception in 1952, we have been the leader in funding cutting-edge diabetes research, supporting nearly 4,600 research projects and investing more than 770 million in diabetes research. In 2016, the Association made more than 34.5 million available to support 378 new and continuing research projects at 150 leading research institutions. The supported projects cover the broad spectrum of research approaches including basic, clinical and translational science and address all types of diabetes, diabetes related disease states and complications. Form 990, Part III, Line 4 The primary goals of the Associations Research Program are Support the highest quality science across the broad spectrum of diabetes research. Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research. Support innovative research with a high potential to have a significant impact for patients with diabetes. Form 990, Part III, Line 4 Peer Review Process One of the factors that sets American Diabetes Association funded research apart and ensures that we are supporting the very best science is peer review. Peer review is a process whereby grant applications are reviewed and evaluated by individuals who are experts in the field or peers of the individual submitting the grant. Association grant applications all undergo peer review by three or more volunteer experts who are themselves diabetes researchers. Reviewers provide both a score and detailed comments regarding the strengths and weaknesses of each grant they review. Scores from all reviewers for each grant are averaged to arrive at a composite merit score that is then used to determine which grants to support. Form 990, Part III, Line 4 Types of Research Awards Research awards are divided into four major categories that reflect our research goals and priorities, provide extraordinary opportunities for researchers from diverse backgrounds, and foster the professional development of young scientists interested in diabetes research. The categories are Investigator-Initiated Awards Core Program Pathway to Stop Diabetes Collaborative Targeted Research and Research Co-Support. Approximately 80 percent of American Diabetes Association-funded research falls under the Core Research Awards. The Association uses a single annual grant application cycle for its Core Research Program, featuring a streamlined grant portfolio. A total of 699 research grant applications were submitted. From those applications, 31 post-doctoral fellowships and 59 research and development grants were selected for funding. Form 990, Part III, Line 4 Research Program Outcomes American Diabetes Association-funded researchers show an exemplary commitment to advancing their careers within the field of diabetes research. Within five years of their award Form 990, Part III, Line 4 99 percent of the researchers we fund remain committed to diabetes research for at least five years 9 out of 10 researchers secure new funding within five years to expand their work, leveraging 7.36 for every 1 invested by the American Diabetes Association Form 990, Part III, Line 4 Pathway to Stop Diabetes Launched in 2013, the American Diabetes Associations Pathway to Stop Diabetes initiative aims to inspire a new generation of diabetes researchers who are early in their career or are established but would like to expand their focus on diabetes research. Through awards of 1.625 million over the course of five to seven years, the program allows researchers to have the time and focus needed to explore new ideas. With a goal of funding 100 new diabetes researchers over the next decade, Pathway provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to new discoveries in diabetes prevention and treatment. Importantly, Pathway is in addition to ongoing Association research activities and is significantly expanding our research efforts. Form 990, Part III, Line 4 Six new Pathway awardees began their research projects in January 2016. During the 2016 calendar year these new awardees, along with the 11 Pathway scientists who were continuing in their second or third years, collectively published 22 high-impact original research manuscripts and four reviews. They delivered 147 presentations at scientific meetings. Through 2016, five Pathway Initiator award recipients of six funded to date have secured their first independent faculty positions. Three patents have been filed by Pathway awardees to date. These outcomes demonstrate that the Pathway initiative continues to meet and exceed its objectives. The Pathway scientists came together at the third annual Pathway to Stop Diabetes Symposium, held at the 76th Scientific Sessions in New Orleans, Louisiana, where the newest cohort of Pathway awardees presented their project plans and progress to date. This exclusive symposium brought the awardees together with the Mentor Advisory Group, program sponsors and philanthropic supporters and Association leadership. The 11 second- and third-year Pathway awardees presented updates on their Pathway grants at special oral and poster sessions that were featured within the official Scientific Sessions program for the first time in 2016. These events allowed the Pathway awardees to share their exciting results and accomplishments with the broader diabetes community at the meeting. Form 990, Part III, Line 4 The fourth annual Pathway to Stop Diabetes grant competition was held in 2016. The Mentor Advisory Group reviewed 106 outstanding nominations and selected six new Pathway Awardees who begin their grants in January 2017. With the selection of these new awardees, the Pathway program has supported 23 outstanding investigators in total. Form 990, Part III, Line 4 2016 Research Highlights Association-supported researchers made significant progress in understanding how diabetes develops and progresses, and in identifying new ways to combat the disease. Notable advances include development and testing of a gene therapy in mice that both stimulates production of new insulin-producing cells and prevents autoimmune attack of the cells, offering a potential cure for type 1 diabetes examination of the best diabetes treatment strategies for older adults who live in long-term care facilities and suffer a high prevalence of type 2 diabetes and the discovery of how high glucose levels disrupt normal wound-healing, a problem that contributes to the high rates of amputation among people with diabetes. Form 990, Part III, Line 4 Headlines from Projects Supported by the American Diabetes Association Research Program in 2016 Pathway Scientist Identifies Possible Trigger for Type 1 Diabetes The Connection between Stress and Type 2 Diabetes New Insight into How Diabetes Leads to Blindness Diabetes in Pregnancy Differs from One Woman to Another Redefining Prediabetes to Prevent Complications A Novel Combination Gene Therapy that Prevents the Autoimmune Attack Causing Type 1 Diabetes Increased Sleep Duration May Help Reduce Depression, a Common Condition for Adolescents with Type 1 Diabetes Determining Whether Genetic differences Affect the Response to GLP-1 Receptor Agonists, an Approved Medication for Type 2 Diabetes Comparing Diabetes Medications in People with Type 2 Diabetes Who Live in Long-term Care Facilities High Blood Glucose Levels Alter the Way a Natural Wound-Healing Molecule Operates Form 990, Part III, Line 4 Scientific Sessions Held annually, Scientific Sessions exemplifies the American Diabetes Associations leadership role in the global diabetes community, while providing a critical platform for driving diabetes awareness. Scientific Sessions is the worlds largest scientific and medical meeting focused on the latest basic and clinical science research related to diabetes and its complications. The 76th Scientific Sessions in New Orleans, Louisiana brought together more than 16,000 scientists and health care providers to learn about the latest in diabetes research, care and education. The meeting met its programmatic and financial goals, while generating more than 700 million audience media impressions worldwide. More than 3,200 abstracts regular and late-breaking combined were received. The 3rd Annual Focus on Fellows program was held in conjunction with the 76th Scientific Sessions. The meeting is dedicated to fostering growth and development of future diabetes clinicians, researchers and leaders. The Association received 680,000 in grants to support 184 fellows. The program boasts significant outcomes including a 20 percent increase in the number of participants with high intentions to remain in diabetes care a 23 percent increase in the number of clinicians with confidence to treat complications a 19 percent increase in confidence to provide self-management education and support and a 34 percent increase in confidence to leverage the latest technologies in care and research. Moreover, 45 percent of participants reportedly initiated the process of incorporating new technologies into their practice and research as a result of the program, and 45 percent modified their patient treatment recommendations to reflect the Associations Standards of Care. Form 990, Part III, Line 4 Information Saving Lives through Knowledge For people affected by or at risk for diabetes, having access to the most up-to-date tools and resources can literally make the difference between life and death. As a trusted leader, the American Diabetes Association works hard to ensure that those affected by and at risk for diabetes, their health care team as well as the general public receive targeted, timely and accurate information. We deliver resources that people can access at any time in multiple formats-from our award-winning website for consumers and professionals, diabetes.org, and our flagship social media channels to our professional journals and publications. Form 990, Part III, Line 4 We focus our efforts on three areas 1. Raising awareness of diabetes as a serious disease. 2. Ensuring patients, providers and care givers have tools and resources to effectively treat and manage diabetes 3. Reaching diverse groups of people who are at risk for or have diabetes, their families and health care professionals, with the goal of reducing the incidence of diabetes and the impact of complications. Form 990, Part III, Line 4 Center for Information The Associations Center for Information CFI at 1-800-DIABETES marks the very first stop for many of our constituents as they start their journey of living with diabetes. In 2016, the center processed nearly 100,000 contacts from constituents, professional members and others. Requests ranged from receiving information and resources for the care and management of diabetes, discrimination issues and enrolling in programs such as Living with Type 2 Diabetes and Care 4 Life, to inquiring about local and national Association events, managing professional memberships and donations. CFI continued to support mission activities by Providing onsite support at Scientific Sessions Promoting Association initiatives such as Step Out, Living With Type 2 Diabetes, American Diabetes Month, Education Recognition Program, and Advocacy including the Insulin Petition Collecting a total of 240,000 in donations Distributing more than 45,000 packets of Association produced information. The Lifestyle Management team updated and developed new materials for the Center for Information training on important topic areas of clinical care and nutrition relevant to people with diabetes. The Nutrition team conducted new call center trainings throughout the year for new staff. Form 990, Part III, Line 4 Digital Engagement We offer a variety of targeted and interactive online properties to connect with our consumer and professional audiences, while providing the latest diabetes related information and news. From our award-winning website, www.diabetes.org, to our Diabetes Stops Here blog and ever-growing presence on Facebook, Twitter, YouTube, Pinterest and Instagram, the American Diabetes Association is there for its constituents 24 7. In 2016, our online properties saw more than 45 million sessions and more than 30 million unique visitors. Form 990, Part III, Line 4 Diabetes.org Our award-winning website for consumers and professionals, diabetes.org, is widely regarded as the most informative and credible diabetes and nutrition resource on the Internet. In 2016, the site had 30 million sessions, up 22 percent from 2015. Form 990, Part III, Line 4 More than 130,000 people registered online for MyFoodAdvisor Recipes for Healthy Living RFHL to receive recipes and nutrition information every month 10 percent increase over 2015, bringing the total number of enrollees to more than 518,000. Our Living With Type 2 Diabetes program saw more than 80,000 total online registrations up 17 percent for English and 10 percent for Spanish over 2015. Form 990, Part III, Line 4 Professional.diabetes.org DiabetesPro www professional diabetes org provides the latest resources in diabetes care and research for health care professionals and scientists. The DiabetesPro professional website had 1.05 million users in 2016 and more than 4.15 million page views in 2016. We completed transition of the site to the open-source platform Drupal, which gives us numerous advantages moving forward, including the ability to provide tiered access to exclusive content for registered site users and professional members making the website mobile friendly and the ability to collect incremental charges for accessing different types of content. The mobile-friendly platform gives the Association enhanced ability to deliver customized members-only content. DiabetesPro is the most advanced professional education website in any branch of medicine, giving those who have placed diabetes in the center of their careers the opportunity to stay informed and take advantage of various resources and educational offerings. Featured content includes diabetes meetings and continuing education opportunities news clinical practice recommendations webcasts and podcasts journals and books research grants recognition programs professional section interest groups We expanded the content on the DiabetesPro site to include a Patient Education Library with approximately 40 Diabetes Advisor pieces on a wide range of topics in diabetes care as well as the Risk Test and several key information pieces on diabetes and prediabetes in 10 different languages. The site had more than 610,000 page views in 2016. The DiabetesPro SmartBrief circulation increased to 55,000 daily opt in subscribers, with an open rate averaging 30 percent, well above average for a daily e-newsletter. The Association worked with the American Medical Group Foundation AMGF on Together 2 Goal, a multi year campaign targeting AMGFs 160,000 primary care physician members to improve health outcomes for at least one million patients with type 2 diabetes. A webinar featuring the Diabetes Self Management Education and Support position statement had more than 100 C-Suite participants from 54 participating health systems. Form 990, Part III, Line 4 Stopdiabetes.com Stopdiabetes.com is the online hub of the American Diabetes Associations Stop Diabetes movement. The site invites visitors to pledge their support, add their name to the map and take action in the Associations fight to Stop Diabetes. Five sections Ways to Act, Whats Happening, Get the Facts, Advocacy Center, and Donate Now provide options for involvement and increased awareness. Form 990, Part III, Line 4 Social Media The Associations flagship social media channels continue to grow Facebook fan base increased by 9.3 percent, ending the year at more than 694,000. Twitter following increased by 16.3 percent, reaching more than 116,000. Pinterest following increased by 26.6 percent, closing 2016 at 12,238. Instagram followers nearly tripled, making this our fastest growing channel. We finished the year with 13,300 followers. LinkedIn became a dedicated marketing communications channel for the professional audience. We grew our company page followers by 20.1 percent to 25,320. YouTube subscribership increased by 21.2 percent to 7,076, and our channel earned an average of 45,000 video views per month. The Associations Diabetes Stops Here blog at diabetesstopshere.org ended 2016 with 2,450 subscribers and drew an average of 31,238 monthly page views, increases of 39.7 percent and 8.4 percent, respectively over 2015. The Associations 76th Scientific Sessions generated more than 700 million media impressions worldwide. Form 990, Part III, Line 4 The Association leveraged new Facebook Live technology to host and co-host several broadcasts throughout the year. Topics included Capitol Hill Advocacy Day Team Tackle launch the National Diabetes Prevention Program with Health Human Services Secretary Sylvia M. Burwell eye health for people with diabetes with NIH oral health with national sponsor Colgate and actress spokesperson Yvette Nicole Brown and Safe at School and a weekly educational series for American Diabetes Month. Form 990, Part III, Line 4 Youth and Diabetes Reaching Type 1 Diabetes Families For children living with type 1 diabetes, the everyday challenges of being a kid must be balanced with the management of a disease that is constant, demanding and scary. They walk a tightrope between blood glucose levels that are too high and those that are too low both of which can be life threatening. Because type 1 diabetes is a life long disease and challenges vary at every stage of life, the American Diabetes Association strives to reach those with type 1 diabetes with relevant programs throughout their life from early diagnosis through adulthood and advanced management. We provide targeted youth programs including Family Link, which connects families to expert guidance, peer support and tools, Diabetes Camps, and other social and educational activities. Form 990, Part III, Line 4 Our Type 1 Diabetes Program Team continues future programming that intends to cover type 1 diabetes needs across the lifespan. The re-designed kit for newly diagnosed children with type 1 diabetes, Courage-Wisdom-Hope Kit, was launched. The kit provides a relevant, appealing and supportive initial experience with the Association for this audience. This kit replaced the Everyday Wisdom Kit and will have an annual distribution of 7,000 thanks to the support of Lilly Diabetes. Form 990, Part III, Line 4 Diabetes Camps The American Diabetes Association continues to be the worlds largest provider of camps for children with diabetes. Our Diabetes Camps have become one of the most powerful and life changing avenues to improve the lives of children affected by diabetes. Offered each summer to nearly 6,000 youth with diabetes across the U S the overarching purpose of our Diabetes Camps is to promote diabetes self care in an environment that is fun, peer oriented and medically safe. Form 990, Part III, Line 4 Since 1947, these camps have provided a traditional summer camp experience while giving children the chance to master basic diabetes self-management skills. At camp, children connect with peers facing the same daily struggles, build their confidence and overcome feelings of isolation and despair. Some campers learn how to inject insulin and count their own carbohydrates for the first time, while others advance their skills in insulin pump use. Form 990, Part III, Line 4 2016 Diabetes Camp Highlights The Association hosted 68 Camp sessions 10 new sessions in 2016 serving more than 6,000 campers and 10,000 parents. Eleven of the camp sessions seven new in 2016 hosted children and families at risk of developing type 2 diabetes, teaching the importance of nutrition and physical activity and making an impact on the growing number of teens at risk of developing the disease. Two new family retreats were added by the CAMP community, engaging parents and children who are newly diagnosed. The Camp team focused on sharing best practices and improving program delivery through meaningful exchanges across Association programs as well as with external partners. Industry and professional partners contributed more than 3.9 million in donated services and supplies. Top supporters included Eli Lilly Company, Novo Nordisk, Sanofi Aventis, Direct Relief, AnimasLifeScan, Medtronic, Omnipod, Insulet, and Novo Diabetes Care Camp supplies include, insulin, meters, pens and needles, strips, lancets and insulin pump supplies. More than 1,000 medical professionals volunteered at CAMP to care for the medical needs of campers with diabetes. During a two month major gift campaign, more than 600,000 was raised to secure matching funds of 250,000 for a total of 867,000, which contributed to family cost subsidies and scholarships. In addition, Lilly Diabetes and The Leona M. and Harry B. Helmsley Charitable Trust gave 193,000 to scholarships for children living with diabetes. Form 990, Part III, Line 4 Living With Type 2 Diabetes In 2016, the Associations New Patient Initiative Living With Type 2 Diabetes enrolled 80,328 new participants, including 7,662 in its Spanish version of the program. This brings the total enrollment to 641,532 participants since the programs inception in 2011. In addition, 5,707 Health Care Providers ordered LWT2 materials for their patients, including 2,650 first time providers. In 2016, the Association applied content and format improvements to LWT2D material, including digital ebooks, which will be rolled out at the beginning of Q2 in 2017. Form 990, Part III, Line 4 Professional Education The primary goal of our professional education program is to affect the quality of treatment and improve patient outcomes for people with diabetes by providing quality education for those health care professionals who provide their care. We conduct professional education activities directed toward enhancing knowledge, competence, advancing skills and apprising health care professionals of the latest developments in diabetes research and clinical practice. The American Diabetes Association has been accredited to provide continuing education to health care professionals for more than 29 years and is accredited by seven accrediting boards. The Association remains in exemplary standing with each accrediting board proving our compliance with the continuing education guidelines. The Association continues to be at the forefront of professional continuing education for the diabetes community as an accredited provider of continuing education credit for all health care professionals on the diabetes management team. Form 990, Part III, Line 4 We expanded the Diabetes Inside program, a systems-based quality improvement program to the Parkland Health and Hospital System in Dallas, Texas, and the INOVA Health Systems in Fairfax, Virginia. The American Diabetes Association received the 2015 Award for Outstanding Continuing Education Outcomes Assessment from the Alliance of Continuing Education in the Health Professions ACEHP and the 2016 Award for Outstanding Innovation in CPD for the CE/CPD Professional and/or Enterprise from the same organization. More grants have been secured and the program will expand to the University of Hawaii Health System in Honolulu, Hawaii, and the Tulane University Health System in New Orleans, Louisiana. This initiative is documenting the achievement of better patient outcomes in health systems in which this program occurs. Form 990, Part III, Line 4 The Association planned and conducted international professional education programs for physicians in Taiwan, Spain, India and Dubai. In addition, the final Train the Trainer programs for physicians in Indonesia 2012-2016 and Vietnam 2013-2016 were held in four locations in 2016. Each of these programs delivered education that is critical to the improvement of clinical care and patient outcomes in the countries where they were implemented. Diabetes Is Primary, an education program for primary care providers that has been held in conjunction with Scientific Sessions for the past five years. In 2016, there were 159 participants in the live meeting, which featured a full day of programming and information to help primary care providers deliver quality care and improve patient outcomes. Within six months after the event, nearly 5,600 individuals participated in the programs webcasts. Form 990, Part III, Line 4 Diabetes INSIDE Inspiring System Improvement with Diabetes Education In July of 2016, the Association completed its acquisition of Intelligent Medical Decisions, Inc. iMD to bring the Diabetes INSIDE DI program in house and expand Diabetes INSIDE to health systems across the country. In June of 2016, the QI Services team presented a poster at Scientific Sessions highlighting the successful completion and results from the Diabetes INSIDE engagements with Inova Health System and the Parkland Health and Hospital System. Inova showed a 19 percent reduction in the proportion of their patients with A1more than 9, and Parkland showed significant process improvements, increasing insulin initiation for patients with A1C more than 9 percent by 24 percent. Several new grants were also awarded to support Diabetes INSIDE at the University of Chicago and Northshore Health focused on reducing CVD risk and a new QI project with Parkland focused on managing obesity in patients with prediabetes. The QI Services team also received a significant legacy grant submitted prior to the acquisition from Genentech to support reducing emergency room use for cancer patients. The learnings from this project will be applied directly to reducing emergency room use and admissions for patients with diabetes. Form 990, Part III, Line 4 The Education Recognition Program ERP continues to operate as the largest and longest standing of the two Medicare National Accrediting Organizations NAO with approximately 1,650 DSME programs, where more than 3,700 sites and over 877,000 patients are served annually. Medicare audits 30 of the recognized ERP programs annually and the 2016 overall audit score was 99.5 percent. ERP staff conducted three successful DSME S symposia during 2016 San Francisco and Los Angeles, California and Raleigh, North Carolina. Each symposium is a live one day program that guides attendees on establishing and maintaining an American Diabetes Association recognized program that adheres to the National Standards for Diabetes Self Management Education and Support. Attendees earned 7.25 hours CME. The events were well attended and participants reported high satisfaction. Based on the success of the 2016 events, four additional symposia are scheduled for 2017, three of which will be hosted by Association field offices. Form 990, Part III, Line 4 Publications The Association published six position statements on psychosocial care, neuropathy, retinopathy, hypoglycemia, lipodystrophy, and exercise physical activity. The position statements provide clinical practice recommendations based on the latest research to improve the care of people with diabetes. The Associations first psychosocial Position Statement, Psychosocial Care for People with Diabetes A position Statement of the American Diabetes Association was published in November 2016. This statement provides recommendations for routine screening of psychosocial issues, including education, diabetes distress, depression, anxiety, disordered eating, and serious mental illness. It calls for referrals to mental health providers with experience in diabetes to improve both health and emotional outcomes. These recommendations were incorporated throughout the 2017 Standard of Care, calling attention to the importance of psychosocial factors in diabetes management and health outcomes and positioning the Association as the leading organization in the area. The first Association Position Statement on Physical Activity Exercise and Diabetes was released in October 2016. The statement covered physical activity and exercise recommendations, disease specific precautions for people with type 1, type 2, and gestational diabetes as well as prediabetes. The proceedings from the fall 2015 research symposium, titled Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis, were epublished in Diabetes in late 2016 and will appear in the February 2017 print issue of Diabetes. The symposium was convened by the American Diabetes Association and included leadership from JDRF, the European Association for the Study of Diabetes and the American Association for Clinical Endocrinology. The publication highlights what experts currently know about how to characterize disease progression of type 1 and type 2 diabetes and how this knowledge may be used to determine the most effective and appropriate treatments at each stage of disease progression. Importantly, the paper describes an expert consensus view that beta cell destruction and or dysfunction underlies the vast majority of diabetes and that identifying the particular cause s of each individuals path to beta cell demise will be critical to applying the most appropriate therapy. To that end, the paper outlines critical research gaps that must be addressed to inform future progress in achieving a personalized approach to diabetes therapy. A workgroup of Quality of Life behavioral experts was brought together to respond to the FDAs request for recommendations on Quality of Life Measures to include in clinical trials. This workgroup presented their consensus recommendations at the FDA on Aug. 29, 2016, which has resulted in a Scientific Statement, Assessing Health Related Quality of Life in People with Diabetes Recommendations by the American Diabetes Association to the FDA to Aid in the Approval of New Therapeutic Strategies and Compare Impact of Therapies Beyond Glycemic Control that will be published in 2017. The Association published a consensus report on the Associations consensus conference on youth-onset type 2 diabetes. Form 990, Part III, Line 4 In addition to our Standards of Medical Care, we published numerous Association position and other professional papers, including the following position and scientific statements Management of Hyperglycemia in Type 2 Diabetes, 2015 A The Standards of Medical Care in Diabetes 2016, the Associations key clinical practice guidelines, was published in January 2016, and was viewed on the Diabetes Care website more than 700,000 times over the course of the year. The Standards of Medical Care in Diabetes 2017 was published online December 15, 2016 and included key changes related to psychological health, access to care, expanded and personalized treatment options, and the tracking of hypoglycemia. The Standards of Medical Care in Diabetes also reached health professionals through a wide variety of additional means in 2016 78,073 downloads of the Standards of Care app 27,782 active users 46,827 views to the abridged Standards of Care, which was published in the winter issue of Clinical Diabetes A continuing education webcast with Robert Ratner, MD, Chief Scientific Medical Officer, complemented the 2016 Standards of Care, along with a comprehensive slides developed for professionals to use in their own presentations. The Primary Care Advisory Group submitted several summary articles on the 2016 Standards, which were published in the Annals of Internal Medicine, Journal of Family Practice, and Osteopathic Family Physician, reaching an additional 240,359 clinicians. Form 990, Part III, Line 4 Awareness and Education Empowering Individuals to Prevent and Manage Diabetes Frustration, confusion, fear, depression these are just some of the more common reactions to a diabetes diagnosis. For those diagnosed with type 2 diabetes, there may be feelings of guilt or responsibility for the illness. And for those with type 1 diabetes, especially for the parents of these young patients, there is real fear and concern for a childs safety, opportunities and the changes that this lifelong disease will bring. All of these feelings can be paralyzing and can affect how patients comply with physician recommendations. Similarly, people who are at risk for developing type 2 diabetes may struggle to take the necessary, proactive steps to prevent diabetes. The American Diabetes Association is leading a multi faceted call to action via targeted public awareness efforts and education programs. We are committed to helping individuals cope with the emotional and health burdens of diabetes and prevent diabetes by making diabetes education accessible for all. We are especially focused on reaching underserved and at risk populations who often face real barriers to accessing this information. Our goal is to ease the burden for patients and families by translating the science for the people and bringing it to them in the places where they live, work and play. The Education Recognition Program ERP continues to operate as the largest and longest standing of the two Medicare National Accrediting Organizations NAO with approximately 1,650 DSME programs, where more than 3,700 sites and over 877,000 patients are served annually. Medicare audits 30 of the recognized ERP programs annually and the 2016 overall audit score was 99.5. ERP staff conducted three successful DSME S symposia during 2016 San Francisco and Los Angeles, California and Raleigh, North Carolina. Each symposium is a live one day program that guides attendees on establishing and maintaining an American Diabetes Association recognized program that adheres to the National Standards for Diabetes Self Management Education and Support. Attendees earned 7.25 hours CME. The events were well attended and participants reported high satisfaction. Based on the success of the 2016 events, four additional symposia are scheduled for 2017, three of which will be hosted by Association field offices. Chronicle Diabetes Diabetes Prevention Program Platform is being implemented in response to Medicares announcement of the expansion of the CDC Diabetes Prevention Program DPP as a covered Part B benefit starting January 1, 2018. This has provided ERP another opportunity to support our current and potential programs. Chronicle CD functionality has been expanded to capture the CDC required DPP data, DPP sessions, and to generate the annual CDC report. The DPP platform will also generate progress reports that will reflect a programs status concerning the CDC required metrics. This platform will be available the first quarter of 2017 to ERP and non ERP programs for a nominal fee. The Associations ERP department and AADE convened 20 workgroup members to review current evidence and revised the 2012 National Standards for Diabetes Self Management Education and Support NSDSME S. The 2017 NSDSME S are scheduled to be published in the Associations October issue of Diabetes Care and the AADE fall issue of The Diabetes Educator. Form 990, Part III, Line 4 Wellness Lives Here Wellness Lives Here, the Associations new corporate engagement strategy, launched in April 2015. This powerful initiative is designed to inspire and fuel our nations healthful habits at work and beyond. With year-round opportunities, Wellness Lives Here helps companies, organizations and communities educate and motivate people to adopt healthful habits to reduce the prevalence of type 2 diabetes. Components that fall under Wellness Lives Here include Health Champion Designation - acknowledges companies and organizations for providing a culture of wellness to their employees Three mission engagement days focused on diabetes risk awareness, physical activity and nutrition Alert Day, National Get Fit Dont Sit Day, National Healthy Lunch Day Stop Diabetes at Work employer resources Diabetes-related resources for employees Participation in Tour de Cure and Step Out Walk to Stop Diabetes CEO Leadership Circle Form 990, Part III, Line 4 American Diabetes Association Alert Day Held on March 22, Alert Day once again drove people to our risk test to learn their risk for type 2 diabetes. At the national level we leveraged the newly launched Ad Council campaign, while our local efforts and Wellness Lives Here toolkit focused on the diabetes.org version of the test. These efforts yielded 12,000 completed risk tests on the prediabetes campaign website and an equal amount on the Associations website, together a 6 single day improvement over total 2015 Alert Day risk tests. On social media, the hashtag prediabetes generated 30 million impressions and the hashtag DiabetesAlertDay generated 41 million impressions. This is a 120 increase in social media mentions and a 74 increase in impressions over Alert Day 2015 results. The hashtags prediabetes and DiabetesAlertDay trended on Twitter and Facebook, respectively. Notable contributors to the social media conversation included Ad Council partners, Dr. Oz, the U.S. Food and Drug Administration, Walgreens, Novo Nordisk, Readers Digest, the San Jose Sharks and the Washington Redskins. Form 990, Part III, Line 4 National Get Fit Dont Sit Day The second annual National Get Fit Dont Sit Day, sponsored by Sun Life Financial, occurred on Wednesday, May 4, and ignited a national conversation about the importance of sitting less and moving more for better health. CEO Kevin L. Hagan invited eight leaders in the health and fitness industry to track their physical activity with a wearable device for the first-ever CEO Fitness Challenge. Participating corporate representatives included Garmin CEO Cliff Pemble, Portland Trailblazers CEO Chris McGowan, Lilly Diabetes President Enrique Conterno, Moda Health CEO Robert Gootee, Sanofi President Jez Moulding, Stridekick COO Anthony Knierim, SunLife Financial VP Ed Milano and challenge winner Merck VP Cathryn E. Gunther, who logged more than 67,000 steps. Kevin stepped into in third place with more than 41,000 steps. Form 990, Part III, Line 4 More than 2,700 people downloaded the etoolkit for use in their companies and organizations. This year the Association introduced new digital assets, including an infographic about the dangers of too much sitting and a series of animated GIFs depicting desk exercises. Online, the hashtag GetFitDontSit had 9.9 million potential social media impressions on May 4, a 13.5 percent increase over 2015. Notable contributors to the social conversation included actress Jessica Marie Garcia, NASCAR Driver Ryan Reed, actress Jillian Rose Reed, television host Maria Menounos and First Lady Michelle Obama s Lets Move campaign. Overall, the campaign earned 220 million impressions, a 461 percent increase over its inaugural year. Form 990, Part III, Line 4 American Diabetes Month Our American Diabetes Month ADM campaign for November featured a compelling new theme, This Is Diabetes, intended to showcase real-life stories of our friends, family and neighbors who are dealing with the day-to-day challenges of the disease. The ThisIsDiabetes storytelling effort was rooted in social media, and our strategic mix of professionally produced story videos, educational Facebook Live broadcasts, infographics and user-generated content earned us more than 1.1 million video views and 3.3 times the hashtag engagement compared to 2015. The campaign earned more than 639 million impressions across all marketing communications channels. Form 990, Part III, Line 4 Americas Diabetes Challenge The Association continues its public awareness initiative with Merck, Americas Diabetes Challenge, which encourages people with type 2 diabetes to get to their A1C goal, and Screen at 23, aimed at educating providers and policy makers about the need to screen Asian Americans for type 2 at a lower BMI than other groups. Form 990, Part III, Line 4 Together 2 Goal The Association worked with the American Medical Group Foundation AMGF on Together 2 Goal, a multi-year campaign targeting AMGFs 160,000 primary care physician members to improve health outcomes for at least 1 million patients with type 2 diabetes. Form 990, Part III, Line 4 Reaching At-Risk Populations Over the years, we have established targeted, culturally sensitive programs and materials to better reach populations that are disproportionally affected by type 2 diabetes. These include at risk populations such as African Americans, Latinos, Asian Americans, Native Hawaiians and Pacific Islanders, American Indians and Alaska Natives, older adults as well as communities in the so called diabetes belt in the Southeast and Appalachia, a region where the incidence of diabetes is significantly higher than the national average. In addition, rates of diabetes in the Latino community are almost double those of non-Latino whites while African Americans are 1.7 times more likely to develop diabetes compared to non-Latino whites. In some Native American communities, one in two adults has diabetes. To help curb this inequity, we have targeted community-based programs in place, working closely with civic, social, faith based and health care representatives within these communities. We also frequently partner with other community and health organizations and host the Disparities Partnership Forum. Our community based, grassroots approach is what makes our programs effective. Our outreach efforts include the following highlights for 2016 Form 990, Part III, Line 4 Six This is Diabetes videos were produced in collaboration with Marketing and Communications and were launched during the 2016 American Diabetes Month on the Associations website and social media platforms. The videos were produced in partnership with several Association volunteers and staff with the purpose to highlight and share diverse journeys from real people living with diabetes or caring for a loved one with diabetes in communities across the country. Form 990, Part III, Line 4 In July 2016, the Association hosted an exhibit booth at the National Council of La Razas 2016 Conference and Expo in Orlando, Florida, with an attendance of about 20,000 people. The Association provided culturally relevant materials and resources for Hispanic/Latino populations in both English and Spanish. Form 990, Part III, Line 4 In August 2016, the Association continued its successful partnership with the Prince Hall Shriners by exhibiting at the 123rd Imperial Sessions of the Prince Hall Shriners in Tampa, Florida, which had more than 15,000 attendees. The Associations booth included several interactive components including a specific area dedicated to healthy eating and promotion of healthy ways to cook traditional soul food dishes. The Association provided educational packets to the Prince Hall Shriners AEANOMS National Diabetes Initiative NDI leaders to continue their efforts to raise awareness for diabetes in the United States and abroad. Educational information and materials were shared with more than 10,000 exhibit visitors over the course of four days. Form 990, Part III, Line 4 In October 2016, the Association attended Healthy Churches 2020 Conference in Charlotte, North Carolina, an annual event for pastors and persons who are responsible for the various aspects of health education, promotion and spiritual connection within the congregation and community. The Association provided resources and encouraged participants to engage their churches in promoting the risk test and participating in International Diabetes Day awareness campaigns. The event was attended by nearly 1,000 representatives of churches across the country. Form 990, Part III, Line 4 In October 2016, the Association supported CBS Radio to raise awareness of Type 2 Diabetes at the For Sisters Only Expo in Washington DC. The event welcomed more than 10,000 women to learn more about health and beauty. The attendees were encouraged to take the risk test and sign up for the Living with Type 2 Diabetes Program. Form 990, Part III, Line 4 Since the successful launch of the pilot in Culpepper, Virginia in April 2016, the Associations collaboration with award winning playwright Garrett Davis, has combined awareness and education in his play Mamas Girls 2 Sugar Aint Sweet. The play centers around five sisters who have come together to take care of their youngest sibling who has just been diagnosed with type 2 diabetes. Together they learn about diabetes and how to take control of their health. In its pilot year, Mamas Girls 2 included 15 shows in 14 cities, reaching a collective audience of nearly 10,000 people. For 2017, the Association is bringing the play under its Live Empowered brand, and complementing it with a community meeting, an educational workshop and various engagement opportunities as it takes this show on the road to several communities around the country. More information about the tour schedule is available at www mamasgirls net Form 990, Part III, Line 4 In June 2016, the Association conducted two days of workshops related to Diabetes Management and offered an interactive booth with resources for more than 10,000 attendees at the National Baptist Congress 110th Annual Session in Birmingham, Alabama. Form 990, Part III, Line 4 In October 2016, the Association participated in the WIDU Radio Anniversary weeklong celebration in Fayetteville, North Carolina, reaching 40,000 people through multiple engagement points over the course of the event, including disseminating information as well as a risk test assessment. The Association also sponsored the 2016 WIDU Womens Empowerment Luncheon, directly providing information to more than 600 women and their loved ones. Form 990, Part III, Line 4 The Association celebrated its 8th Annual John Pipe Voices for Change Award, recognizing Special Diabetes Program for Indians SDPI grantees for their effective diabetes prevention and treatment services in the American Indian and Alaska Native communities Innovative Program - Chinle Service Unit, Leadership Excellence - Yakama Indian Health Service Healthy Heart Program, Outcomes Achievement - Cheyenne River Sioux Tribe Youth Diabetes Prevention Program Form 990, Part III, Line 4 The pilot outcomes data from the What Can I Eat Food Choices for People with Diabetes program show high satisfaction and significant impact on key dietary behaviors e.g. increased vegetable consumption and decreased sugary drink and sweet/salty snack consumption, including food preparation methods e.g. increased use of the diabetes plate method and decreased use of solid fats and frying, frequency of eating at restaurants, and food label usage. Program participants were also more confident in their ability to change their diet and make healthy choices in social settings. Positive trends in A1C, weight, and blood pressure were also observed. Based on the outcomes from the pilot, the program was refined, simplified and redesigned to include more group interaction and discussion as well as components of physical activity, stress reduction and goal setting in each session. The updated program is currently in its second round of pilots in Mobile and Tuscaloosa, Alabama. Form 990, Part III, Line 4 What Can I Eat Food Choices for People with Diabetes program for Association Staff The Nutrition team provided two programs four weekly sessions at 90 minutes per session for about 12 Association staff members across the National office and 10 Association call center staff. This provided our new dietitians experience facilitating the program, which was well received by staff. It also provided more program and Nutrition team visibility across the Association. Form 990, Part III, Line 4 Signature Campaigns Our special events are yet another opportunity for the American Diabetes Association to raise awareness about diabetes and are an integral part of our strategic vision to eradicate the disease. In 2016, all of the Associations events including our signature events Step Out Walk to Stop Diabetes and Tour de Cure, incorporated our educational message and brought awareness of the seriousness of diabetes. The 14th Annual Kiss a Pig Gala Uncle Ham Wants You in Bentonville, Arkansas, had another record breaking year, which raised 1.13 million with 2,000 attendees Step Out Walk to Stop Diabetes, the Associations premier walk event, conducted 86 walks nationwide with more than 53,000 participants and raised nearly 12.6 million. The three top national sponsors were Walgreens, Wellcare, and Walmart, who collectively raised more 411,000. Other top teams included Novo Nordisk, Dignity Memorial, AstraZeneca, Camp, Advocates, and Team Red. Step Out Chicagoland takes the top fundraising event for the second year in a row. The city also took the top Walk for 2016 with 840,000 in sponsorships and 2,650 walkers. Over the last two years, the event has raised more than 1.8 million. Tour de Cure, the Associations premier cycling event, featured 81 Tours across the country with more than 48,400 participants raising more than 25.5 million. Our nationwide teams grossed more than 5 million collectively, including Lockheed Martin, Walmart, Johnson and Johnson, Lilly Diabetes, Dignity Memorial, Golds Gym and many others. Chicagos Father of the Year was once again the top Father of the Year event in the country, raising more than 671,000. Colorado secured 600,000 in grants to provide Diabetes Prevention Program to over 200 people with a total weight loss of 1,571 pounds in 2016. Clinical Conference in Florida reached 515 healthcare professionals in 2016. Since 1997, this field based professional activity has generated nearly 6 million in revenue for the Association and reached more than 10,200 health professionals. Minnesota relationships generated the Medtronic sponsorship of 250,000 for the American Diabetes Month campaign. Michigan secured a Meijer contract for 460,000 over two years that supports Step Out and Camp in Michigan, Illinois, Ohio, Wisconsin and Indiana. Form 990, Part III, Line 4 Advocacy Speaking Up for All People with Diabetes The American Diabetes Associations advocacy efforts and achievements are at the core of creating effective and lasting change for people living with and at risk for diabetes. Raising our voices from Capitol Hill to state houses to court houses across the country, our dedicated Diabetes Advocates continue to drive momentum in our ongoing fight to Stop Diabetes. Our advocacy work gives people with diabetes, their families and health care professionals the power to influence public policy issues that affect people with diabetes at the local, state and national levels. Our primary goals are Form 990, Part III, Line 4 to increase federal and state funding for diabetes prevention, treatment and research to prevent diabetes to improve the availability of accessible, adequate and affordable health care to end the discrimination people with diabetes face at school, work and elsewhere in their lives. Form 990, Part III, Line 4 We have trained advocates around the country who represent those with diabetes who need a raised voice to protect their rights. An ever growing volunteer network of attorneys, health care professionals and advanced school advocates help thousands facing discrimination because of their diabetes. Form 990, Part III, Line 4 The Association set an ambitious goal of recruiting 58,200 new advocates to grow our grassroots network by 20 percent in 2016. Through successful efforts with the Capitol Hill Advocacy Day petition, Insulin Affordability petition, June Advocate Recruitment Month campaign, and recruiting at local market events, we recruited over 192,807 new advocates and ended the year with 488,285 advocates in our grassroots network in 2016. This is a 65 percent increase in advocates over the course of the year, which represents 330 percent of our recruiting goal for the year. We also achieved a 33 percent increase in legal advocacy volunteers and key changes to our legal advocate program resulted in our helping nearly three times as many individuals facing discrimination. Form 990, Part III, Line 4 The Centers for Medicare and Medicaid Services announced Medicare will cover participation in the National Diabetes Prevention Program National DPP for seniors at risk for type 2 diabetes. The benefit goes into effect nationwide in January of 2018. This success is the result of nearly a decade of advocacy. Our work to establish the National DPP within the Affordable Care Act, successful advocacy for federal funding to expand the infrastructure of the program, and countless meetings with legislators to promote the Medicare Diabetes Prevention Act all led to HHS Secretary Sylvia Burwells announcement in March that the Administration would move forward in adding this benefit to Medicare and to the final rule published in November. Form 990, Part III, Line 4 To date, the Association has achieved 61 state legislative and regulatory wins with some bills still pending. Among the wins, three states passed Safe at School legislation addressing key aspects of school diabetes care, 14 states improved health insurance laws, and 10 states passed legislation to reduce health disparities. The Associations legislative success was bolstered through deepening our volunteer engagement locally. During 2016, we reached volunteers in 41 markets with in person training. Form 990, Part III, Line 4 The Association filed a lawsuit against the U.S. Army Child, Youth and School Services for its discriminatory policy prohibiting the administration of insulin and glucagon as well as failing to provide other essential care for children with diabetes. This lawsuit represents a significant commitment by the Association to protecting the rights of children with diabetes and securing safe access to the programs available to children who do not have diabetes. Form 990, Part III, Line 4 We achieved significant strides in increasing affordable access to care. The Administration adopted over 10 federal regulatory recommendations made by the Association. In addition, we launched the Insulin Affordability campaign, gathering over 135,000 signatures on our petition in the first month of the campaign and receiving bi-partisan support on Capitol Hill. Overall, we received 151,400 signatures in 2016. Form 990, Part III, Line 4 In addition, Team Tackle is an initiative that brings together current and former professional football players and the American Diabetes Association to draw increased attention to diabetes. By uniting current and former professional football players from all professional teams who are committed to increasing diabetes awareness, Team Tackles goal is to Elevate the profile of the gravity of diabetes and prediabetes Champion additional research, fair treatment and total wellness for all people living with diabetes Provide hope for the millions of individuals and families who are managing diabetes or are at risk for developing the disease. Form 990, Part III, Line 4 The Associations marquee activation with Team Tackle was held on April 6-7, 2016, Capitol Hill Advocacy Day. Thirty four players participated in 73 meetings with members of Congress and their staffs. There was also a livestreamed panel discussion at the White House featuring Association officers and Team Tackle members Rashad Jennings, Aaron Murray and Sam Acho. The Association leveraged the partnership for greater exposure to the cause and the actions the Association was taking to bring positive change to the lives of people with diabetes. As a result, there were 203 media clips including USA Today, The Washington Post and The Hill. There were also 6.9 million TeamTackle social impressions between April 5-8, 2016. Form 990, Part III, Line 4 Since June, there have been 30 Team Tackle member activations or appearances these have included three ADA camp appearances participation in Association fundraising events advocacy emails sent on behalf of players Diabetes Dance Dare participation Charity Cleats awareness efforts, various Tour de Cure and Step Out support activities online fundraising for the Association specifically through Cheerful Giving, among many others. Form 990, Part III, Line 4 The My Cause My Cleats initiative gave professional football players the opportunity to increase visibility and raise funds for the charities they care about through the personalization of their game day cleats. Following the game, players then had the chance to auction off their cleats through various fundraising platforms with the proceeds benefiting the individual charity that the cleats represent. Ultimately 11 players, including Team Tackle members Donta Hightower and Shane Ray, wore customized American Diabetes Association cleats during week 13 of the 2016 season. Form 990, Part III, Line 4 Just Imagine Imagine the day when diabetes will no longer devastate our families and communities, our neighbors near and far. When a parent does not have to hear that their child has an incurable disease that brings with it not only sleepless nights, but constant fears about possible complications and diabetes related discrimination. When nobody has to worry anymore about blood glucose highs and lows and whether that blurred vision is the beginning of a life without sight. When a family can gather at a family reunion and create happy memories instead of having to gather at a graveside and saying goodbye to a loved one who has lost their battle against diabetes. We know that, together, we can stop this dreadful disease and realize our vision life free of diabetes and all its burdens. Learn more at diabetes.org and stopdiabetes.com. Form 990, Part III, Line 4 Continued Other Program Services revenue reported in Line 4d 1,675,645 relates to the investment in real estate. This investment represents a 1998 donor bequest that restricted the Association from selling the property for 25 years. A portion of the property is leased to corporations and derives monthly rental income that is reported in investment income. Form 990, Part VI, Section A, Line 6,7a The American Diabetes Association has established the voting membership of the Association as the National Leadership Council. The National Leadership Council is comprised of all of the members of the Board of Directors and additional delegates. The National Leadership Council votes on the election of the organizations governing body each year. No governance decisions are reserved to or subject to approval by the membership. Form 990, Part VI, Section B, Line 11 IRS Review Process by the Governing Body The American Diabetes Association Board of Directors assigns the Audit Committee the oversight responsibility of the IRS Form 990 and its supplemental schedules prior to completion. After review by management and KPMG, the final signed 990 was provided to the Associations Board of Directors prior to filing with the IRS. Form 990, Part VI, Section B, Line 12 Managing Conflict of Interest To identify potential conflicts of interest with appropriate due diligence, Officers, Directors, and members of select Board appointed committees and their related subcommittees, journal/periodical editors, and senior staff of the Association must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in Legal Affairs manage the disclosure and monitoring processes. Through review of the annual disclosures and review of the agendas of the relevant Board ,Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. Based on the situation, senior volunteers and staff presiding over the discussion are responsible to ensure appropriate action is taken for the individual to publicly disclose the conflict, for the individual to recuse him or herself from the discussion, vote or room as appropriate and to ensure the disclosure and action is documented in the minutes of the meeting. Form 990, Part VI, Section B, Line 15a Compensation Process Annually, The American Diabetes Association Principal Officers Chair of the Board President, Medicine Science President, Health Care Education and Secretary/Treasurer are responsible for establishing executive compensation consistent with the guidelines approved by the Compensation Committee. The Principal Officers of the Association use a Compensation Committee, compensation studies and an in dependent consultant to establish the compensation of the Chief Executive Officer and other Key employees. The Chief Executive Officer is responsible for the individual performance evaluations of staff officers and key employees, and establishes the total compensation for key employees subject to the guidelines established by the Executive Compensation Committee. The Executive Compensation Committee develops guidelines for the key employee executive positions listed below following the process described in the IRS intermediate sanctions rules when determining compensation. Specifically, the Committee 1 Is composed entirely of non-employee volunteer leaders who have no familial, business or significant personal relationships with the American Diabetes Association or its executives 2 Assesses the short-term and long-term contribution and performance of CEO and other senior executive employees in meeting very definitive and quantifiable objectives focused on the Associations mission success 3 Engages an independent compensation consulting firm to compile appropriate comparability data including compensation market information for peers with whom the American Diabetes Association competes for executive talent. 4 The Committee reviews this data in detail for all elements of each executives total compensation, including but not limited to base salary, bonuses, perquisites, fringe benefits, and incentive and deferred compensation arrangements. Upon the executives hire, and at each point in time thereafter at which a new or revised compensation arrangement is under consideration with respect to the executive, the Committee meets before the arrangement is implemented to evaluate the reasonableness of the arrangement by comparing both the arrangement itself and the executives entire compensation package to compensation packages paid by similarly situated organizations for functionally comparable positions 5 Documents, concurrently with its determination, the basis for its determination in the minutes of its meeting These minutes are reviewed, revised if necessary and approved at the following meeting of the Executive Compensation Committee. The process described above was used to establish compensation for the following positions Chief Executive Officer, Chief Field Development Officer, Chief Financial Officer, Chief Medical Officer, Chief Revenue Officer, Executive Vice President of Government Affairs Advocacy, Senior Vice President and Chief Technology Officer, Senior Vice President of Human Resources, Senior Vice President of Marketing Communications. The total compensation of executives at the American Diabetes Association is specifically designed to attract and retain the highest qualified executive talent to fulfill the critically important mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Form 990, Part VI, Section C, Line 17 Filing Jurisdiction Registration Number Alabama-AL97-256, Alaska-N/A, Arizona-10145, Arkansas-N/A, California-CT81471, Colorado-2002-3003670, Connecticut-5084, District of Columbia-981855, Florida-CH1618, Georgia-CH-001422, Hawaii-N/A, Illinois-CO 01-025537, Indiana-000103829-000, Kansas- 177-257-3SO, Kentucky-45, Louisiana-N/A, Maine- CO-1247, Maryland-102, Massachusetts-029317, Michigan-MICS 10326, Minnesota-N/A, Mississippi- 100000294, Missouri- CO-021-87, New Hampshire-5006, New Jersey- CH-0581900, New Mexico-N/A, New York- 1/30/1965, North Carolina- SL000618, North Dakota-7894, Ohio- 01-0239, Oklahoma- N/A, Oregon- 16402, Pennsylvania- No. 21, Rhode Island-95-233, South Carolina-641, Tennessee-5104, Utah- 6536093-Char, Virginia-N/A, Washington-7664, West Virginia-N/A, Wisconsin- 3020-800. Form 990, Part VI, Section C, Line 19 The following information is available on the American Diabetes Associations website http//www.diabetes.org Board of Directors, Audited Consolidated Financial Statements, Latest 990 filed, Whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following Current Bylaws, Articles of Incorporation, Conflict of Interest Policy. Form 990, Part VII, Section A, Line 1a19 The Chief Executive Officer of the Association is a non-voting member of the Board of Directors. Form 990, Part VI, Section A, Line 9 Employment term for Robert Ratner, Chief Scientific and Medical Officer ended in December 19, 2016. Employment term for Jeanette Flom, VP Eastern Division ended in September 16, 2016. Employment term for Rodney Sampson, SVP ITS and Chief Technical Officer ended in July 22, 2016. Employment term for Peter Banfield, SVP Operations Integration ended in December 5, 2016. Employment term for Jane Chiang, SVP Medical Community Affairs ended in November 25, 2016. Form 990, Part III, Line 4 Publications The Association published six position statements on psychosocial care, neuropathy, retinopathy, hypoglycemia, lipodystrophy, and exercise physical activity. The position statements provide clinical practice recommendations based on the latest research to improve the care of people with diabetes. The Associations first psychosocial Position Statement, Psychosocial Care for People with Diabetes A position Statement of the American Diabetes Association was published in November 2016. This statement provides recommendations for routine screening of psychosocial issues, including education, diabetes distress, depression, anxiety, disordered eating, and serious mental illness. It calls for referrals to mental health providers with experience in diabetes to improve both health and emotional outcomes. These recommendations were incorporated throughout the 2017 Standard of Care, calling attention to the importance of psychosocial factors in diabetes management and health outcomes and positioning the Association as the leading organization in the area. The first Association Position Statement on Physical Activity Exercise and Diabetes was released in October 2016. The statement covered physical activity and exercise recommendations, disease specific precautions for people with type 1, type 2, and gestational diabetes as well as prediabetes. The proceedings from the fall 2015 research symposium, titled Differentiation of Diabetes by Pathophysiology, Natural History and Prognosis, were epublished in Diabetes in late 2016 and will appear in the February 2017 print issue of Diabetes. The symposium was convened by the American Diabetes Association and included leadership from JDRF, the European Association for the Study of Diabetes and the American Association for Clinical Endocrinology. The publication highlights what experts currently know about how to characterize disease progression of type 1 and type 2 diabetes and how this knowledge may be used to determine the most effective and appropriate treatments at each stage of disease progression. Importantly, the paper describes an expert consensus view that beta cell destruction and or dysfunction underlies the vast majority of diabetes and that identifying the particular cause s of each individuals path to beta cell demise will be critical to applying the most appropriate therapy. To that end, the paper outlines critical research gaps that must be addressed to inform future progress in achieving a personalized approach to diabetes therapy. A workgroup of Quality of Life behavioral experts was brought together to respond to the FDAs request for recommendations on Quality of Life Measures to include in clinical trials. This workgroup presented their consensus recommendations at the FDA on Aug. 29, 2016, which has resulted in a Scientific Statement, Assessing Health Related Quality of Life in People with Diabetes Recommendations by the American Diabetes Association to the FDA to Aid in the Approval of New Therapeutic Strategies and Compare Impact of Therapies Beyond Glycemic Control that will be published in 2017. The Association published a consensus report on the Associations consensus conference on youth-onset type 2 diabetes. American Diabetes Association Research Foundation Inc 2451 Crystal Drive Ste 900 Arlington VA 22202 541734511 See Part VII VA 501 c 3 7 American Diabetes Association true American Diabetes Association Property Title Holding Corporation 2451 Crystal Drive Ste 900 Arlington VA 22202 541948004 See Part VII VA 501 c 2 N/A American Diabetes Association true false true false false false false false false false false false true false true true false false false true American Diabetes Association Research Foundation Inc b 34227945 Cash American Diabetes Association Research Foundation Inc l,n,o 1382769 Fair Value estimated based on donation activity American Diabetes Association Property Title Holding Corporation s 1675645 Cash Part II Line 1b The Foundations objective is to secure major gifts and grants to fund diabetes related research leading to the prevention and cure of diabetes, the prevention and cure of the complications of diabetes, and new therapies for individuals affected by diabetes. Part II Line 2b The mission of the American Diabetes Association Property Title Holding Corp. is to hold title to real property, collect the income therefrom, and remit to the American Diabetes Association.